News | June 30, 2014

Froedtert & the Medical College of Wisconsin First in U.S. to Use Monaco 5 Treatment Planning With Siemens mARC Radiotherapy Technique

June 30, 2014 — Clinicians at Froedtert & the Medical College of Wisconsin Clinical Cancer Center are achieving excellent planning results in the first U.S. combination of Elekta's Monaco 5 radiotherapy treatment planning software and Siemens' mARC (modulated arc) therapy technique. The Froedtert & the Medical College team treated their first patient, an individual with prostate cancer, using the combination of Monaco 5 and mARC on March 26.

"mARC is a form of volumetric modulated arc therapy [VMAT], which has significant advantages over step-and-shoot IMRT in radiotherapy delivery speed and/or dose conformity, so we were eager to get mARC working on our Siemens treatment machine," said X. Allen Li, Ph.D., chief physicist, department of radiation oncology at Froedtert & the Medical College of Wisconsin Clinical Cancer Center. "The first case was a complex two-arc plan for treating both pelvic nodes and prostate bed, but on pre-treatment verification we achieved 99 percent agreement between the measured dose distribution and the plan dose distribution, which is very good. And, we've been able to replicate this accuracy in most of cases measured so far."

Li added that the two-arc treatment took eight minutes to deliver, faster than conventional step-and-shoot IMRT delivery. Furthermore, the cancer center plans to add flattening filter-free (FFF) beams in this summer, which will significantly speed up mARC delivery. 

"Planning mARC delivery with Monaco 5 is straightforward," stated Li. "From the dosimetrist's standpoint, there is not much difference planning between mARC and other delivery techniques, so in a sense, workflow is identical. Having multiple treatment methods in Monaco 5 is a significant improvement over previous versions and the Monaco 5 contouring tools are excellent — we can contour using multi-modality images, such as those from CT, MRI and PET. I also really like the biological-based optimization, which gives us more flexibility in terms of shaping the dose distribution."

Introduced last year, the latest version of Monaco 5 consolidates the best of Elekta's treatment planning solutions into a single, comprehensive system. A vendor-neutral solution, Monaco 5 allows advanced treatment plans to be created faster and features a completely new user interface. As in all Monaco releases, this new version employs the Monte Carlo dose engine, considered the gold standard for calculating radiation dose.

For more information: www.elekta.com, www.froedtert.com

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init